Bausch confirms end of two Retin-A products in Canada; remaining stock expected until March
Retin-A 0.05% cream and 0.025% gel are being discontinued for business reasons, Bausch told CTV News. Pharmacists warn alternatives may cost more.
In this article & details
Bausch Health has confirmed that it is ending Canadian sales of Retin-A tretinoin cream 0.05% and gel 0.025%, with existing inventory expected to last until approximately March or until supplies run out.
The company told CTV News by email on November 17 that the decision was made for business reasons, unrelated to safety, effectiveness or product quality.
Other tretinoin treatments remain available
In CTV’s November 18 report, University of Toronto pharmacy professor Mina Tadrous said other tretinoin formulations and related medicines remain available and urged patients not to stockpile.
Toronto pharmacist Alexandre Mihaila said changing treatments can involve new adverse effects and higher costs. Dalhousie pharmacy instructor Sarah Larose noted that other medicines in the retinoid class may be options, with availability and drug-plan coverage affecting the choice.
CTV cited a Beyond Health listing of more than $100 for 50 grams of Retin-A Micro, compared with roughly $40 for 30-gram tubes of the discontinued products. Those are different package sizes and formulations, rather than a direct price comparison.
The discontinuation affects the two specified Retin-A products; it does not mean all tretinoin treatments are disappearing from Canada.
References
- Popular prescription acne medication discontinued in Canada — CTV News, November 18, 2026; manufacturer confirmation November 17
Discussion
0 commentsJoin the discussion. Anyone can read the comments. To comment, log in or create a free individual account.
No comments yet.